These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 28694914)

  • 21. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
    Souza PR; Norling LV
    Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
    Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
    FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.
    Zhang MJ; Spite M
    Annu Rev Nutr; 2012 Aug; 32():203-27. PubMed ID: 22404117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
    Norling LV; Ly L; Dalli J
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining proteins with n-3 PUFAs (EPA + DHA) and their inflammation pro-resolution mediators for preservation of skeletal muscle mass.
    Blaauw R; Calder PC; Martindale RG; Berger MM
    Crit Care; 2024 Feb; 28(1):38. PubMed ID: 38302945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
    Calder PC
    Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What the surgeon needs to know about basic new concepts of inflammation and their therapeutic consequences: sanitation of inflammation is not a passive but rather an active process regulated by lipid mediators].
    Gardemann A; Meyer F; Braun-Dullaeus R
    Zentralbl Chir; 2013 Jun; 138(3):322-30. PubMed ID: 23807584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.
    Serhan CN
    J Periodontol; 2008 Aug; 79(8 Suppl):1520-6. PubMed ID: 18673006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
    Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease.
    Daak AA; Lopez-Toledano MA; Heeney MM
    Complement Ther Med; 2020 Aug; 52():102482. PubMed ID: 32951732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
    Al-Shaer AE; Buddenbaum N; Shaikh SR
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
    Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
    Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders.
    Parolini C
    Life Sci; 2020 Dec; 263():118591. PubMed ID: 33069735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
    Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
    Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoxins and resolvins in inflammatory bowel disease.
    Weylandt KH; Kang JX; Wiedenmann B; Baumgart DC
    Inflamm Bowel Dis; 2007 Jun; 13(6):797-9. PubMed ID: 17262807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
    Seki H; Tani Y; Arita M
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
    Schunck WH; Konkel A; Fischer R; Weylandt KH
    Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.